Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Glatiramer Acetate (Prefilled Syringes Only), (Obo), Atc L03Ax13 For The Period 01.12.2024 - 30.11.2026

DAK-Gesundheit Germany has Released a tender for Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Glatiramer Acetate (Prefilled Syringes Only), (Obo), Atc L03Ax13 For The Period 01.12.2024 - 30.11.2026 in Pharmaceuticals. The tender was released on Oct 16, 2024.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Glatiramer Acetate (Prefilled Syringes Only), (Obo), Atc L03Ax13 For The Period 01.12.2024 - 30.11.2026

Deadline - Oct 05, 2026

MT reference number - 95634489

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 95634489

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Scope of procurementBrief descriptionSection 130a paragraph 8 of the Social Code Book V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs dispensed at the expense of t he statutory health insurance companies. In view of the relevant legal provisions for awarding public contracts, a regular process of active ingredient-related, formal award procedures takes place through DAK-Gesundheit in accordance with the regulations of Part 4 of the GWB. For drugs containing the above-mentioned active ingredient, glatiramer acetate (only pre-filled syringes), ATC L03AX13, which are to be specified by the bidder in Annex 2 to

Mt Ref Id - 95634489

Deadline - Oct 05, 2026

Share

Similar Tenders :